Jiangsu Asieris Pharmaceutical Technology Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai China (2010)

Organization Overview

First Clinical Trial
2018
NCT03672240
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Asieris Pharmaceuticals (AUS) Pty Ltd. | Asieris Pharmaceutical Technologies Co., Ltd. | Jiangsu Yahong Meditech Co.,Ltd. | Jiangsu Yahong Meditech Co., Ltd aka Asieris